Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

EXtubatie-gerelateerde complicaties - het EXTUBE-onderzoek (EXTUBE) (EXTUBE)

19 oktober 2026 bijgewerkt door: University Health Network, Toronto

EXtubatiegerelateerde complicaties - een internationaal observationeel onderzoek om de impact en de beste praktijken in de operatiekamer en de intensive care te begrijpen - het EXTUBE-onderzoek

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Studie Overzicht

Toestand

Werving

Conditie

Gedetailleerde beschrijving

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Studietype

Observationeel

Inschrijving (Geschat)

3000

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

  • Naam: Shayan Wasim, MPH, BSc
  • Telefoonnummer: 4221 +1 416 340 4800
  • E-mail: shayan.wasim@uhn.ca

Studie Locaties

    • New South Wales
      • Sydney, New South Wales, Australië, 2065
        • Voltooid
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, Australië, 3135
        • Voltooid
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, Australië, 3156
        • Voltooid
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, Australië, 3076
        • Voltooid
        • The Northern Hospital
      • Melbourne, Victoria, Australië, 3128
        • Voltooid
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, Australië, 3084
        • Voltooid
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, Australië, 3079
        • Voltooid
        • Austin Health - Heidelberg Repatriation Hospital
    • British Columbia
      • Surrey, British Columbia, Canada, V3V 1Z2
        • Voltooid
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, Canada, E1C 4B7
        • Voltooid
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, Canada, M4N 3M5
        • Voltooid
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, Canada, L2S 0A9
        • Voltooid
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, Canada, M5B 1W8
        • Voltooid
        • St. Michael's Hospital
      • Toronto, Ontario, Canada, M5G 1X5
        • Voltooid
        • Mount Sinai Hospital
      • Toronto, Ontario, Canada, M5G 2C4
        • Werving
        • University Health Network - Toronto General Hospital
        • Contact:
        • Hoofdonderzoeker:
          • Matteo Parotto, MD, PhD
        • Contact:
        • Onderonderzoeker:
          • Alicia Grassi, MD
      • Toronto, Ontario, Canada, M5T 2S8
        • Voltooid
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, Canada, H2X 0C1
        • Voltooid
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Piedecuesta, Colombia
        • Voltooid
        • Hospital Internacional de Colombia
      • Castlebar, Ierland, F23 H529
        • Voltooid
        • Mayo University Hospital
      • Cork, Ierland, T12 DFK4
        • Voltooid
        • Cork University Hospital
      • Dublin, Ierland, D07 R2WY
        • Voltooid
        • Mater Misericordiae University Hospital
      • Galway, Ierland, H91 YR71
        • Voltooid
        • Galway University Hospitals
      • Waterford, Ierland, X91 ER8E
        • Nog niet aan het werven
        • University Hospital Waterford
        • Contact:
        • Contact:
        • Hoofdonderzoeker:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • Onderonderzoeker:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
      • Kuwait City, Koeweit
        • Voltooid
        • Amiri Hospital
      • Auckland, Nieuw-Zeeland, 1023
        • Voltooid
        • Auckland City Hospital
      • Invercargill, Nieuw-Zeeland, 9812
        • Voltooid
        • Southland Hospital
      • Rotorua, Nieuw-Zeeland, 3010
        • Voltooid
        • Rotorua Hospital
      • Singapore, Singapore, 308433
        • Voltooid
        • Tan Tock Seng Hospital
      • Bath, Verenigd Koninkrijk, BA1 3NG
        • Voltooid
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, Verenigd Koninkrijk, NE7 7DN
        • Voltooid
        • Freeman Hospital
    • Arizona
      • Tucson, Arizona, Verenigde Staten, 85724-5114
        • Voltooid
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, Verenigde Staten, 72205
        • Voltooid
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, Verenigde Staten, 32608
        • Voltooid
        • University of Florida
    • Illinois
      • Chicago, Illinois, Verenigde Staten, 60637
        • Voltooid
        • The University of Chicago
    • Oregon
      • Portland, Oregon, Verenigde Staten, 97239
        • Voltooid
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, Verenigde Staten, 77030
        • Voltooid
        • The University of Texas Health Science Center

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Kanssteekproef

Studie Bevolking

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

Beschrijving

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Observatiemodellen: COHORT
  • Tijdsperspectieven: PROSPECTIVE

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Tijdsspanne: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Difficult airway and complications related to airway management if reintubation is required
Tijdsspanne: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Tijdsspanne: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
Tijdsspanne: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Tijdsspanne: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
Tijdsspanne: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
Tijdsspanne: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
Tijdsspanne: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
Tijdsspanne: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
Tijdsspanne: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
Tijdsspanne: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
Tijdsspanne: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
Tijdsspanne: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Matteo Parotto, MD, PhD, UHN

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

14 april 2025

Primaire voltooiing (Geschat)

1 december 2027

Studie voltooiing (Geschat)

1 december 2027

Studieregistratiedata

Eerst ingediend

28 maart 2024

Eerst ingediend dat voldeed aan de QC-criteria

3 juni 2024

Eerst geplaatst (Werkelijk)

5 juni 2024

Updates van studierecords

Laatste update geplaatst (Werkelijk)

22 oktober 2026

Laatste update ingediend die voldeed aan QC-criteria

19 oktober 2026

Laatst geverifieerd

1 augustus 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • 24-5811
  • 4850 (Andere identificatie: Clinical Trials Ontario - CTO)

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren